Table 6.
Drug |
Dr. PRODIS |
DTINet |
||
---|---|---|---|---|
Sensitivity for top 50 predicted targets | Sensitivity for top 200 predicted targets | Sensitivity for top 50 predicted targets | Sensitivity for top 200 predicted targets | |
Sorafenib | 18% | 7.5% | 14% | 3.5% |
Dasatinib | 10% | 21.5% | 20% | 5% |
Imatinib | 14% | 27.5% | 18% | 4.5% |
Sunitinib | 14% | 8% | 16% | 4% |
Pazopanib | --- | --- | --- | --- |
Average | 14% | 16% | 17% | 4.3% |